Alzamend Neuro

About:

Alzamend Neuro is an innovative biotechnology company that develops and commercializes drugs, treatments, and cures for Alzheimer's disease.

Website: https://alzamend.com/

Twitter/X: alzamendneuro

Description:

Alzamend Neuro is an innovative biotechnology company that develops and commercializes drugs, treatments, and cures for Alzheimer's disease. The company also focused on the facilitation of bringing technologies to market which help with the treatment, prevention, or cure of Alzheimer’s. They providing hope through the commercialization of existing patented intellectual property while simultaneously funding future treatments through advanced research and development. Alzamend Neuro was founded in 2016 and is headquartered in Newport Beach, CA, USA.

Total Funding Amount:

$25M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Newport Beach, California, United States

Founded Date:

2016-01-01

Contact Email:

Info(AT)Alzamend.com

Founders:

Milton Ault III

Number of Employees:

1-10

Last Funding Date:

2024-05-09

IPO Status:

Public

Industries:

© 2025 bioDAO.ai